FTC sues significant pharmacy advantage administrators over insulin price ranges The agency introduced motion in opposition to Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the record price of lifestyle-saving insulin medication. Now that some digital health startups funded through the height of https://kethek.com/